Joint Corp Ownership
| JYNT Stock | USD 11.33 0.14 1.22% |
Joint Stock Ownership Analysis
About 74.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.1. Joint Corp had not issued any dividends in recent years. The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona. Joint Corp operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 316 people. To learn more about The Joint Corp call Sanjiv Razdan at 480 245 5960 or check out https://www.thejoint.com.Joint Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Joint Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Joint Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Joint Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bandera Partners Llc over a year ago Acquisition by Bandera Partners Llc of 1961 shares of Joint Corp at 13.0741 subject to Rule 16b-3 | ||
Matthew Rubel over a year ago Disposition of tradable shares by Matthew Rubel of Joint Corp subject to Rule 16b-3 | ||
Jake Singleton over a year ago Payment of 708 shares by Jake Singleton of Joint Corp subject to Rule 16b-3 | ||
John Meloun over a year ago Acquisition by John Meloun of 12000 shares of Joint Corp subject to Rule 16b-3 |
Joint Corp Outstanding Bonds
Joint Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Joint Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Joint bonds can be classified according to their maturity, which is the date when The Joint Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Joint Stock Analysis
When running Joint Corp's price analysis, check to measure Joint Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Joint Corp is operating at the current time. Most of Joint Corp's value examination focuses on studying past and present price action to predict the probability of Joint Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Joint Corp's price. Additionally, you may evaluate how the addition of Joint Corp to your portfolios can decrease your overall portfolio volatility.